Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Zeynep Köksal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Abietanes, Carbonic Anhydrase Inhibitors. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Istanbul Medeniyet University.
Abstract (Originalsprache)
This study investigates the anticholinesterase (acetylcholinesterase [AChE] and butyrylcholinesterase [BChE]) and carbonic anhydrase (CAI and CAII) inhibitory activities of carnosic acid and its natural derivatives, including carnosol, rosmanol, 7‐methoxy‐rosmanol, 12‐methoxy‐carnosic acid, and isorosmanol. Among the tested compounds, rosmanol demonstrated exceptional potency, with IC 50 values of 0.73 nM for AChE and 0.75 nM for BChE, significantly outperforming tacrine. Rosmanol also exhibited remarkable inhibition of CA I (IC 50 = 0.21 nM), surpassing acetazolamide by over 450‐fold, and moderate inhibition of CAII. Molecular docking and molecular mechanics generalized born surface area (MM‐GBSA) studies revealed strong binding affinities for rosmanol, with docking scores of −11.757 kcal/mol (AChE) and −11.465 kcal/mol (BChE). The MM‐GBSA binding free energy calculations further confirmed stable interactions for CA I (−63.24 kcal/mol) and AChE (−60.09 kcal/mol). Molecular dynamics simulations over 50 ns showed stable enzyme‐ligand complexes, particularly for AChE and BChE (root mean square deviation ~1.5 Å), with key residues identified as crucial for stabilization. Other derivatives also displayed significant inhibitory activities, suggesting their potential as secondary leads. The ADMET analysis showed favorable pharmacokinetics and rosmanol emerged as a promising candidate. This comprehensive study highlights rosmanol as a multitarget therapeutic agent with potent anticholinesterase and CA inhibitory properties, offering promise for treating neurodegenerative and metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, Istanbul, Türkiye.
- Science and Advanced Technologies Research Center (BILTAM), Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Türkiye.
Förderung
- Istanbul Medeniyet University
Zitieren
APA
Köksal, Z., & Şenol, H. (2025). Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400909
Vancouver
Köksal Z, Şenol H. Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400909
BibTeX
@article{Kksal2025,
author = {Köksal, Zeynep and Şenol, Halil},
title = {Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: A comprehensive in vitro and in silico study},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400909}
}
EUVIMED